Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation

Transplant International

Volumn 20, Issue 11, 2007, Pages 962-969

  Faguer, Stanislas ^a   Hirsch, Hans H ^b,c   Kamar, Nassim ^a   Guilbeau Frugier, Celine ^d   Ribes, David ^a   Guitard, Joëlle ^a   Esposito, Laure ^a   Cointault, Olivier ^a   Modesto, Anne ^d   Lavit, Michel ^d   Mengelle, Catherine ^d   Rostaing, Lionel ^a  

^a CHU RANGUEIL   (France)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d CHU PURPAN   (France)

Author keywords

Anemia; Immunosuppression; Kidney transplantation; Leflunomide; Polyomavirus BKV associated nephropathy; Serum creatinine

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; ERYTHROPOIETIN; EVEROLIMUS; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; LEFLUNOMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VINCRISTINE; VORICONAZOLE;

ADULT; ANEMIA; ARTICLE; BIOPSY; BK VIRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; HYPOGAMMAGLOBULINEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LOADING DRUG DOSE; LOW DRUG DOSE; MALE; OPEN STUDY; PNEUMONIA; POLYOMAVIRUS ASSOCIATED NEPHROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; URETER OBSTRUCTION; URINARY TRACT DISEASE; VIREMIA;

ADULT; ANTIVIRAL AGENTS; BK VIRUS; FEMALE; HUMANS; IMMUNOSUPPRESSION; ISOXAZOLES; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS; TUMOR VIRUS INFECTIONS;

EID: 35148839477     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00523.x     Document Type: Article

References (32)

1. Randhawa P, Brennan DC. BK virus infection in transplant recipients: an overview and update. Am J Transplant 2006 6: 2000.
2. Randhawa PS, Finkelstein S, Scantelbury V, et al. Human polyomavirus-associated interstitial nephritis in the allografts kidney. Transplantation 1999 67: 103.
3. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003 3: 611.
4. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus ciclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005 5: 582.
5. Lipshutz GS, Flechner SM, Govani MV, Vicenti F. BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppressive regimen. Am J Transplant 2004 4: 2132.
6. Kazory A, Ducloux D, Chalopin JM, et al. The first case of JC virus allograft nephropathy. Transplantation 2003 15: 1653.
7. Wen MC, Wang CL, Wang M, et al. Association of JC virus with tubulointerstitial nephritis in a renal allograft recipient. J Med Virol 2004 72: 675.
8. Randhawa P, Uhrmacher J, Pasculle W, et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol 2005 77: 238.
9. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002 347: 488.
10. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analysis and recommendations. Transplantation 2005 79: 1277.
11. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant 2004 4: 2082.
12. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005 5: 582.
13. Kuypers DR, Vandooren AK, Lerut E, et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005 5: 1997.
14. Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation 2006 81: 117.
15. Williams JW, Javaid B, Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005 352: 1157.
16. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006 81: 704.
17. Chong AS, Huang W, Liu W, et al. In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. Transplantation 1999 65: 100.
18. Hardinger KL, Wang CD, Schnitzler MA, et al. Prospective, pilot, open-label, short term study of conversion to leflunomide reverses chronic renal allograft dysfunction. Am J Transplant 2002 2: 867.
19. Savikko J, von Willebrand E, Hayry P, et al. Leflunomide analogue FK778 is vasculoprotective independent of its immunosuppressive effect: potential applications for restenosis and chronic rejection. Transplantation 2003 76: 455.
20. Kyles AE, Gregory CR, Griffey SM, et al. Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs. Transplantation 2003 75: 1128.
21. Chong AS, Zeng H, Knight DA, et al. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant 2006 6: 69.
22. Limaye AP, Jérôme KR, Kuhr CS, et al. Quantitation of BK virus load in serum for the diagnosis of BK-virus associated nephropathy in renal transplant recipients. J Infect Dis 2001 183: 1669.
23. Chan V, Charles BG, Tett SE. Rapid determination of the active leflunomide metabolite A77 126 in human plasma by high-performance liquid chromatography. J Chromatogr 2004 803: 331.
24. Nickeleit V, Mihatsch MJ. Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threat. Transpl Int 2006 19: 960.
25. Hussain S, Orentas R, Walczak J, et al. Prevention of BKV nephritis by monitoring BK viremia in renal transplant recipients: a prospective study. Graft 2004 7: 28.
26. Funk GA, Steiger J, Hirsch HH. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis 2006 193: 80.
27. Josephson MA, Williams JW, Chandraker A, Randhawa PS. Polyomavirus-associated nephropathy: update on antiviral strategies. Transplant Infect Dis 2006 8: 95.
28. Bressollette-Bodin C, Coste-Burel M, Hourmant M, et al. A prospective longitudinal study of BK virus infection in 104 renal transplant patients. Am J Transplant 2005 5: 1926.
29. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999 67: 918.
30. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyomavirus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002 13: 2145.
31. Vasudev B, Hariharan S, Hussain SA, et al. BK virus nephritis: risk factors, timing and outcomes in renal transplant recipients. Kidney Int 2005 65: 1834.
32. Wadei HM, Rule AD, Lewin M, et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant 2006 6: 1025.